Biogen scores FDA approval for generic eye disease biologic
The Cambridge drugmaker has nabbed an approval from the U.S. Food and Drug Administration for a biosimilar that can treat three disorders causing progressive blindness.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
More News: Blindness | Food and Drug Administration (FDA) | Health Management | Opthalmology | Pharmaceuticals